ADIM
CPAY icon

Alpha DNA Investment Management’s Corpay CPAY Stock Holding History

Alpha DNA Investment Management’s Portfolio CPAY Stock Details CPAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,598
Closed -$426K – 263
2024
Q2 		$426K Buy
1,598
+344
+27% +$97.4K 0.17% 145
2024
Q1 		$387K Sell
1,254
-176
-12% -$50.5K 0.14% 171
2023
Q4 		$404K Buy
1,430
+617
+76% +$153K 0.16% 153
2023
Q3 		$208K Buy
+813
New +$213K 0.09% 163

Other funds holding CPAY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Orbis Allan Gray
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Alpha DNA Investment Management's CPAY Position: Q3 2024 in Review

Alpha DNA Investment Management sold out of Corpay (CPAY) in Q3 2024, closing a stake of 1,598 shares — an estimated $426K sold.

Alpha DNA Investment Management first reported a position in CPAY in Q3 2023 and held it in 4 quarters. The position peaked at $426K in Q2 2024. 614 funds tracked by Wall St. Rank hold CPAY as of Q3 2024.

  • Alpha DNA Investment Management reported no remaining Corpay position as of Q3 2024 after selling out during the quarter.
  • Alpha DNA Investment Management sold 1,598 Corpay shares in Q3 2024, an estimated $426K.
  • Alpha DNA Investment Management first reported a position in Corpay in Q3 2023 and held it in 4 quarters.
  • Alpha DNA Investment Management's Corpay position peaked at $426K in Q2 2024.
  • 614 funds tracked by Wall St. Rank held Corpay as of Q3 2024.

Based on Alpha DNA Investment Management's 13F filing for Q3 2024, filed 12 Nov 2024.